MeiraGTx Holdings plc (NASDAQ: MGTX) announced that the FDA granted Breakthrough Therapy Designation for its AAV2-hAQP1 treatment for Grade 2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE